Scholar Rock (NASDAQ:SRRK) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?

Scholar Rock logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Scholar Rock shares rose above their 50-day moving average, trading as high as $48.57 versus the average of $45.54 and last changing hands at $48.00.
  • Analyst sentiment remains broadly positive but mixed: the consensus is “Moderate Buy” with a $69.50 price target, while some firms recently downgraded their ratings.
  • The company reported a quarterly loss of $0.81 per share, beating the $0.85 loss analysts expected; director Srinivas Akkaraju also bought 146,970 shares for about $6.1 million.
  • Five stocks to consider instead of Scholar Rock.

Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report)'s share price crossed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $45.54 and traded as high as $48.57. Scholar Rock shares last traded at $48.00, with a volume of 2,774,436 shares trading hands.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Wolfe Research cut Scholar Rock from an "outperform" rating to a "peer perform" rating in a research note on Thursday, November 12th. Cantor Fitzgerald restated a "neutral" rating and issued a $70.00 price target on shares of Scholar Rock in a research report on Monday, September 21st. BMO Capital Markets increased their target price on shares of Scholar Rock from $76.00 to $84.00 and gave the company an "outperform" rating in a research note on Monday, September 14th. Barclays lowered shares of Scholar Rock from an "overweight" rating to a "cautious" rating in a report on Tuesday, September 15th. Finally, Wedbush reiterated an "outperform" rating and set a $64.00 price target on shares of Scholar Rock in a report on Tuesday, September 15th. Three research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $69.50.

View Our Latest Stock Report on Scholar Rock

Scholar Rock Stock Performance

The firm has a market cap of $5.86 billion, a price-to-earnings ratio of -14.29 and a beta of 0.78. The company has a debt-to-equity ratio of 1.16, a current ratio of 5.41 and a quick ratio of 5.40. The firm has a fifty day simple moving average of $45.54 and a two-hundred day simple moving average of $48.24.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last posted its quarterly earnings results on Tuesday, November 10th. The company reported ($0.81) earnings per share for the quarter, beating the consensus estimate of ($0.85) by $0.04. The firm had revenue of $0.57 million for the quarter, compared to analysts' expectations of $0.30 million. During the same quarter in the previous year, the firm posted ($0.90) EPS. On average, analysts expect that Scholar Rock Holding Corporation will post -3.04 EPS for the current year.

Insider Buying and Selling

In other Scholar Rock news, Director Srinivas Akkaraju bought 146,970 shares of the firm's stock in a transaction dated Monday, October 26th. The shares were purchased at an average price of $41.59 per share, for a total transaction of $6,112,482.30. Following the transaction, the director directly owned 6,380,517 shares of the company's stock, valued at approximately $265,365,702.03. This represents a 2.36% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 10.30% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in SRRK. Allworth Financial LP acquired a new position in Scholar Rock in the 2nd quarter valued at about $35,000. PNC Financial Services Group Inc. increased its stake in Scholar Rock by 92.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,270 shares of the company's stock worth $62,000 after acquiring an additional 610 shares during the last quarter. IFP Advisors Inc raised its position in Scholar Rock by 219.0% in the third quarter. IFP Advisors Inc now owns 1,560 shares of the company's stock valued at $75,000 after purchasing an additional 1,071 shares during the period. GAMMA Investing LLC raised its position in Scholar Rock by 20.8% in the second quarter. GAMMA Investing LLC now owns 1,406 shares of the company's stock valued at $77,000 after purchasing an additional 242 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new position in Scholar Rock in the second quarter valued at about $99,000. 91.08% of the stock is owned by institutional investors and hedge funds.

Scholar Rock Company Profile

(Get Free Report)

Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-β) superfamily, which plays roles in processes including muscle development and immune regulation. The company's lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients' motor function.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scholar Rock Right Now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines